Accuray Appoints Sandeep Chalke as SVP, Chief Commercial Officer
Summary
SUNNYVALE, Calif., May 17, 2022 /PRNewswire/ -- Accuray Inc. (NASDAQ: ARAY) announced today that Sandeep Chalke has joined the company as senior vice president, chief commercial officer effective May 16, 2022. Mr. Chalke will have responsibility for the global commercial, product development, R&D and engineering functions for the company reporting to Accuray president and forthcoming CEO, Suzanne Winter. Mr. Chalke brings more than 25 years of medical device expertise in commercialization, business development and operations, spanning multiple healthcare industry segments including interventional catheterization systems, diagnostic x-ray, C-arm linear accelerators, anesthesia and respiratory care, advanced wound dressing & diabetes. "I am thrilled to join the Accuray team and have been impressed with the organizations passion and commitment to creating a better future for cancer patients through technology innovation and advancing radiation therapy care. We invent unique, market-changing solutions that are designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs.